medicalxpress - A federal court in Virginia has ruled that restrictions imposed by the U.S. drug regulator on the abortion pill mifepristone are "unlawful" and ordered the Trump administration to reconsider them.
AI Summary: A U.S. court ruled recent restrictions on the abortion pill unlawful, reaffirming FDA regulatory standards and restoring broader access. Industry groups filed briefs backing FDA oversight, warning that legal uncertainty would harm patients and research. The ruling calms access for now while legal and policy debates continue.
FDA to Remove Black Box Warnings from Menopausal Hormone Therapies / 8 months
FDA scrutinizes peptide injections popularized by RFK Jr. and influencers / 2 days
Supreme Court preserves telehealth and mail access to abortion pill / 2 months
FDA updates mifepristone safety review, but pharmacies remain reluctant / 3 months
FDA clears first new sunscreen ingredient in two decades / 6 wks
FDA commissioner Marty Makary resigns amid mounting scrutiny / 2 months
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.